Concepedia

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

Jean‐Yves Blay, Zsuzsanna Pápai, Anthony W. Tolcher, Antoîne Italiano, Didier Cupissol, Antonio López–Pousa, Sant P. Chawla, Emmanuelle Bompas, Nada Babović, Nicolas Penel,

The Lancet Oncology · 2015 · 66 citations · 34 references

DOI

Concepts

References

34

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, N. Abecassis, Sebastian Bauer et al. · Annals of Oncology · 2018 · 1.6K citations · Full text

, , +17

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology · 2014 · 658 citations

, , +16

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

Robert G. Maki, David R. D’Adamo, Mary Louise Keohan et al. · Journal of Clinical Oncology · 2009 · 573 citations · Full text

, , +15

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

J H Edmonson, Louise Ryan, Ronald H. Blum et al. · Journal of Clinical Oncology · 1993 · 518 citations

, , +13

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas

Mark Agulnik, Jessica Lee Yarber, Scott H. Okuno et al. · Annals of Oncology · 2012 · 390 citations · Full text

, , +17